Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of 5,6,7,8- trihydroxy-8-methoxyflavone in preparing anti-hypoxic drug

A technology of methoxyflavonoids and anti-hypoxia drugs, applied in the field of medicine, can solve unseen and other problems

Active Publication Date: 2014-06-25
中国人民解放军联勤保障部队第九四〇医院
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no report on the biological activity of 5,6,7-trihydroxy-8-methoxyflavone

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 5,6,7,8- trihydroxy-8-methoxyflavone in preparing anti-hypoxic drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] tablet:

[0059] 5,6,7-trihydroxy-8-methoxyflavone (purity greater than 95%) 50.0g,

[0060] Starch (Shaanxi Aoke Pharmaceutical Excipients Co., Ltd.) 130.0g,

[0061] Microcrystalline cellulose (MCC, Shaanxi Aoke Pharmaceutical Excipients Co., Ltd.) 10.0g,

[0062] Methylcellulose (Anhui Shanhe Pharmaceutical Excipients Co., Ltd.) 6.0g,

[0063] Magnesium stearate (Shaanxi Aoke Pharmaceutical Excipients Co., Ltd.) 4.0g,

[0064] 200.0g total.

[0065] Prepared according to the conventional tablet method, a total of 1000 tablets were made, and each tablet contained 50 mg of 5,6,7-trihydroxy-8-methoxyflavone.

Embodiment 2

[0067] Capsules:

[0068] 5,6,7-trihydroxy-8-methoxyflavone (purity greater than 95%) 50.0g,

[0069] Starch 135.0g,

[0070] Methylcellulose 5.0g,

[0071] Magnesium Stearate 10.0g,

[0072] 200.0g total.

[0073] Prepared according to the conventional method of capsules, 1000 capsules are prepared in total, and each capsule contains 50 mg of 5,6,7-trihydroxy-8-methoxyflavone.

Embodiment 3

[0075] Dispersible tablets:

[0076] 5,6,7-trihydroxy-8-methoxyflavone (purity greater than 95%) 50.0g,

[0077] Microcrystalline cellulose (MCC) 130.0g,

[0078] Croscarmellose sodium (cCMC-Na) 20.0g,

[0079] 200.0g total.

[0080] Prepared according to the conventional method for dispersible tablets, a total of 1000 tablets were made, each containing 50 mg of 5,6,7-trihydroxy-8-methoxyflavone.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of 5,6,7,8- trihydroxy-8-methoxyflavone in preparing an anti-hypoxic drug which is the drug for preventing and treating hypoxic injury diseases; the hypoxic injury diseases are high-altitude low-pressure oxygen deficit-caused acute high altitude diseases, cerebral ischemia hypoxic diseases or myocardial ischemia hypoxic diseases. The application has beneficial effects as follows: an experiment proves that the 5,6,7,8- trihydroxy-8-methoxyflavone has a remarkable anti-hypoxic effect, and an effect tending to be better than that of acetazolamide; the anti-hypoxic drug prepared by applying the 5,6,7,8- trihydroxy-8-methoxyflavone as an active ingredient can be used for preventing and treating hypoxic injuries or treating various hypoxic pathological states caused by oxygen content drop in external environment, also can be used for preventing or treating hypoxic pathological states of heart, brain, respiratory system, and the like as external normal oxygen cannot sufficiently get to a body due to diseases, and the like, and further can be used for preventing or treating the pathological state that relative oxygen supply is insufficient as oxygen consumption needed for activities of the body exceeds physiological mobilization ability.

Description

technical field [0001] The invention relates to the field of medicine, in particular to the application of 5,6,7-trihydroxy-8-methoxyflavone in the preparation of anti-hypoxic drugs. Background technique [0002] With the change of people's lifestyle and the accelerated pace of life, hypoxia has become a fairly common pathological process. The main causes of hypoxia are: low oxygen content or partial pressure in the atmosphere in the environment, respiratory, blood Circulation and other system diseases lead to oxygen supply and oxygen utilization disorders and the body's oxygen consumption is greater than the supply. The low-pressure and hypoxic environment in plateau areas often makes people who are new to the plateau prone to acute altitude sickness such as headache, palpitations, chest tightness, shortness of breath, fatigue, sleep disturbance, nausea, and vomiting. In severe cases, high-altitude pulmonary edema and high-altitude cerebral edema may also occur. Long-term ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/352A61P39/00A61P9/10
Inventor 景临林马慧萍樊鹏程蒙萍王宁贾正平
Owner 中国人民解放军联勤保障部队第九四〇医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com